NCT03751072View on ClinicalTrials.gov

Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO)

UnknownOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

November 30, 2018

Study Completion Date

January 30, 2019

Conditions
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed Remission
Trial Locations (1)

75010

RECRUITING

CABANNES-HAMY Aurélie, Paris

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Group for Research in Adult Acute Lymphoblastic Leukemia

OTHER